Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alzamend Neuro, Inc. Director's Dealing 2021

Sep 17, 2021

35321_dirs_2021-09-16_7206e7b8-a085-448c-a23d-94d49c046e5f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alzamend Neuro, Inc. (ALZN)
CIK: 0001677077
Period of Report: 2021-09-14

Reporting Person: AULT MILTON C III (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-14 Common Stock P 5000 $2.6984 Acquired 6720388 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-16 Call Option (right to buy) $2.50 P 180 Acquired 2022-02-18 Common Stock (18000) Indirect
2021-09-16 Call Option (right to buy) $10.00 P 200 Acquired 2022-02-18 Common Stock (20000) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 150000 Direct
Common Stock 15000000 Indirect
Common Stock 10000000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Call Option (right to buy) $5.00 2022-02-18 Common Stock (50000) 500 Indirect
Call Option (right to buy) $7.50 2022-02-18 Common Stock (5000) 50 Indirect

Footnotes

F1: Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.

F2: Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.

F3: Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.

F4: The security listed is an exchange-traded option contract. Exchange-traded options are immediately exercisable and remain exercisable until expiration.

F5: The options were purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $93.3891. The range of purchase prices on the transaction date was $91.511 to $96.511. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of options purchased at each price.